Cargando…
Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543686/ https://www.ncbi.nlm.nih.gov/pubmed/33049598 http://dx.doi.org/10.1016/j.thromres.2020.09.039 |
_version_ | 1783591713432928256 |
---|---|
author | Trunfio, Mattia Salvador, Elena Cabodi, Daniela Marinaro, Letizia Alcantarini, Chiara Gaviraghi, Alberto Trentalange, Alice Lipani, Filippo Sciascia, Savino Roccatello, Dario Bonora, Stefano Di Perri, Giovanni Calcagno, Andrea |
author_facet | Trunfio, Mattia Salvador, Elena Cabodi, Daniela Marinaro, Letizia Alcantarini, Chiara Gaviraghi, Alberto Trentalange, Alice Lipani, Filippo Sciascia, Savino Roccatello, Dario Bonora, Stefano Di Perri, Giovanni Calcagno, Andrea |
author_sort | Trunfio, Mattia |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7543686 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75436862020-10-09 Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection Trunfio, Mattia Salvador, Elena Cabodi, Daniela Marinaro, Letizia Alcantarini, Chiara Gaviraghi, Alberto Trentalange, Alice Lipani, Filippo Sciascia, Savino Roccatello, Dario Bonora, Stefano Di Perri, Giovanni Calcagno, Andrea Thromb Res Letter to the Editors-in-Chief Elsevier Ltd. 2020-12 2020-10-08 /pmc/articles/PMC7543686/ /pubmed/33049598 http://dx.doi.org/10.1016/j.thromres.2020.09.039 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editors-in-Chief Trunfio, Mattia Salvador, Elena Cabodi, Daniela Marinaro, Letizia Alcantarini, Chiara Gaviraghi, Alberto Trentalange, Alice Lipani, Filippo Sciascia, Savino Roccatello, Dario Bonora, Stefano Di Perri, Giovanni Calcagno, Andrea Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection |
title | Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection |
title_full | Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection |
title_fullStr | Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection |
title_full_unstemmed | Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection |
title_short | Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection |
title_sort | anti-xa monitoring improves low-molecular-weight heparin effectiveness in patients with sars-cov-2 infection |
topic | Letter to the Editors-in-Chief |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543686/ https://www.ncbi.nlm.nih.gov/pubmed/33049598 http://dx.doi.org/10.1016/j.thromres.2020.09.039 |
work_keys_str_mv | AT trunfiomattia antixamonitoringimproveslowmolecularweightheparineffectivenessinpatientswithsarscov2infection AT salvadorelena antixamonitoringimproveslowmolecularweightheparineffectivenessinpatientswithsarscov2infection AT cabodidaniela antixamonitoringimproveslowmolecularweightheparineffectivenessinpatientswithsarscov2infection AT marinaroletizia antixamonitoringimproveslowmolecularweightheparineffectivenessinpatientswithsarscov2infection AT alcantarinichiara antixamonitoringimproveslowmolecularweightheparineffectivenessinpatientswithsarscov2infection AT gaviraghialberto antixamonitoringimproveslowmolecularweightheparineffectivenessinpatientswithsarscov2infection AT trentalangealice antixamonitoringimproveslowmolecularweightheparineffectivenessinpatientswithsarscov2infection AT lipanifilippo antixamonitoringimproveslowmolecularweightheparineffectivenessinpatientswithsarscov2infection AT sciasciasavino antixamonitoringimproveslowmolecularweightheparineffectivenessinpatientswithsarscov2infection AT roccatellodario antixamonitoringimproveslowmolecularweightheparineffectivenessinpatientswithsarscov2infection AT bonorastefano antixamonitoringimproveslowmolecularweightheparineffectivenessinpatientswithsarscov2infection AT diperrigiovanni antixamonitoringimproveslowmolecularweightheparineffectivenessinpatientswithsarscov2infection AT calcagnoandrea antixamonitoringimproveslowmolecularweightheparineffectivenessinpatientswithsarscov2infection |